No harm from angiotensin-converting enzyme inhibitors or angiotensin receptor inhibitors in patients with COVID-19. Results of a prospective study on a hospital-based cohort. Italian Journal of Medicine, [S. l.], v. 14, n. 3, p. 162–166, 2020. DOI: 10.4081/itjm.2020.1313. Disponível em: https://www.italjmed.org/ijm/article/view/itjm.2020.1313. Acesso em: 1 jul. 2025.